CSL Limited

Director, Search & Evaluation Early TA Lead (CVR)

CSL Limited$150K — $180K *
Pharmaceuticals & Biotech
5 - 7 years of experience
Job Overview by Ladders

Qualifications

  • Significant tenure in biopharma with experience in external innovation, search & evaluation, or business development.
  • Advanced degree required (PhD, MD, or equivalent).
  • Deep scientific expertise in Cardiovascular/Renal.
  • Proven track record of leading due diligence and closing early-stage deals.
  • Strong network within biotech, academia, and pharma BD organizations.

Responsibilities

  • Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy.
  • Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets.
  • Co-lead internal meetings on evaluating and prioritizing New Product Opportunities (NPOs).
  • Develop and execute early partnering strategies for priority assets.
  • Drive cross-functional due diligence for each opportunity, coordinating assessments.
  • Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities.
  • Represent the TA externally, leading sourcing activities and cultivating relationships.

Benefits

  • Hybrid work model, requiring onsite presence (3 days a week) at R&D hub sites.
  • Opportunity to shape the future of the Cardiovascular/Renal portfolio.
  • Engagement with cross-functional teams and external partners.
  • Access to specialized conferences and networking with biotech and investment communities.
Full Job Description

CSL is expanding its external innovation capability, and we're looking for a Director of Search & Evaluation to help shape the future of our Cardiovascular/Renal portfolio.

We are seeking a Director of Search & Evaluation to lead strategic sourcing and evaluation of external innovation opportunities in the Cardiovascular/Renal therapeutic area. Embedded within the Therapeutic Area Leadership Team (TALT), this position will identify and advance high-potential assets from preclinical through Phase 1 clinical stages, shape early partnering strategies, and drive transactions in collaboration with Business Development.

To be hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely.

Main Responsibilities & Accountabilities

  • Serve as the senior Early S&E leader within the TALT, influencing therapeutic strategy and ensuring external innovation priorities are integrated into portfolio planning.​

  • Lead proactive sourcing and scouting efforts for preclinical and Phase 1 assets, building a robust pipeline of opportunities aligned with TA strategy. ​

  • Co-lead internal meetings (with Late Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Cardiovascular/Renal. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations​.

  • Develop and execute early partnering strategies, including onboarding approaches and competitive positioning for priority assets.​

  • Drive cross-functional due diligence for each opportunity, coordinating scientific, clinical, regulatory, and commercial assessments to inform governance decisions.​

  • Transaction Execution: Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution​.

  • Represent the TA externally, leading sourcing activities at specialized conferences and cultivating relationships with biotech, academia, and investment communities.​

Qualifications & Experience Requirements

  • Significant tenure in biopharma with significant experience in external innovation, search & evaluation, or business development.​

  • Advanced degree required (PhD, MD, or equivalent).​

  • Must have deep scientific expertise in Cardiovascular/Renal​.

  • Proven track record of leading due diligence and closing early-stage deals.​

  • Strong network within biotech, academia, and pharma BD organizations.​

About CSL Limited

CSL Limited is a global biotechnology company that develops and delivers innovative biotherapies and influenza vaccines to protect public health. They have a focus on rare and serious diseases, and their products are used in more than 70 countries. CSL Limited was founded in 1916 in Australia, and has since grown to become one of the largest biotech companies in the world. They have a strong commitment to research and development, and invest heavily in new technologies and therapies. CSL Limited is listed on the Australian Securities Exchange and the NASDAQ, and has a market capitalization of over $100 billion.
Learn more about CSL Limited
Size
25,000 employees
Industry
Founded
1904
NASDAQ

Similar Jobs

More Jobs at CSL Limited

More Pharmaceuticals & Biotech Jobs

Find similar Director, Search & Evaluation Early TA Lead (CVR) jobs: